is allulose a glp-1 agonist preliminary study of people with diabetes suggests that use of glucose-lowering drugs may be linked to a lower risk of developing epilepsy. The study was published on December 10, 2025 The Metabolic and Endocrine Effects
Pay in 4 interest-free payments of $5.43 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2




:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)























